The novel phospho-non-steroidal anti-inflammatory drugs, OXT-328, MDC-22 and MDC-917, inhibit adjuvant-induced arthritis in rats

Functions of nuclear factor κB in bone

(2010) Brendan F. Boyce et al.   Annals of the New York Academy of Sciences

Adverse effects of non-steroidal anti-inflammatory drugs (NSAIDs, aspirin and coxibs) on upper gastrointestinal tract

(2010) Carlos Sostres et al.   BEST PRACTICE & RESEARCH IN CLINICAL GASTROENTEROLOGY

Phospho-Sulindac (OXT-328), a Novel Sulindac Derivative, Is Safe and Effective in Colon Cancer Prevention in Mice

(2010) Gerardo G. Mackenzie et al.   GASTROENTEROLOGY

NSAIDs and risk of lower gastrointestinal bleeding

(2010) Elham Rahme et al.   LANCET

NO-NSAIDs: Gastric-sparing nitric oxide-releasable prodrugs of non-steroidal anti-inflammatory drugs

(2009) Kumar V.S. Nemmani et al.   BIOORGANIC & MEDICINAL CHEMISTRY LETTERS

A Novel Sulindac Derivative That Does Not Inhibit Cyclooxygenases but Potently Inhibits Colon Tumor Cell Growth and Induces Apoptosis with Antitumor Activity

(2009) G. A. Piazza et al.   Cancer Prevention Research

Phosphoaspirin (MDC-43), a novel benzyl ester of aspirin, inhibits the growth of human cancer cell lines more potently than aspirin: a redox-dependent effect

(2009) W. Zhao et al.   CARCINOGENESIS

Cytokines and Cytokine Profiles in Human Autoimmune Diseases and Animal Models of Autoimmunity

(2009) Manfred Kunz et al.   MEDIATORS OF INFLAMMATION

NF- B as a Critical Link Between Inflammation and Cancer

(2009) M. Karin   Cold Spring Harbor Perspectives in Biology

The Thioredoxin System Mediates Redox-Induced Cell Death in Human Colon Cancer Cells: Implications for the Mechanism of Action of Anticancer Agents

(2008) Y. Sun et al.   CANCER RESEARCH

The roles of the classical and alternative nuclear factor-kappaB pathways: potential implications for autoimmunity and rheumatoid arthritis

(2008) Keith D Brown et al.   ARTHRITIS RESEARCH & THERAPY

The roles of prostanoids, leukotrienes, and platelet-activating factor in bone metabolism and disease

(2007) Hisako Hikiji et al.   PROGRESS IN LIPID RESEARCH